Katie Adams / medcitynews - Ascension is set to acquire Williamson Health, a county-owned health system in Tennessee, in a deal worth nearly $1 billion. Ascension’s offer beat out bids from HCA Healthcare and Optum. The post Ascension to Buy Tennessee Health System for Nearly $1B ap…
AI Summary: Ascension announced plans to buy Williamson Health, an independent Tennessee health system, in a transaction valued at roughly $700M–$1B. The acquisition further consolidates hospital ownership in the region and will shift local governance and operational control to Ascension as the parties work through regulatory and integration steps.
medicalxpress - A parasite that causes severe, watery diarrhea is spreading across the United States, and health officials in Michigan are racing to explain an unusual surge in cases.
AI Summary: Health officials are investigating an unusual surge in a parasite that causes violent, watery diarrhea, with Michigan among the hardest-hit areas. Public-health teams are tracing exposures, warning vulnerable populations, and urging hygiene measures as cases cluster across multiple states. The outbreak has prompted CDC tracking and local alerts amid rising gastrointestinal illness reports.
Mariah Taylor / beckershospitalreview - Front-line healthcare workers at the epicenter of the Ebola outbreak in the Democratic Republic of Congo went on strike over a lack of pay and poor working conditions, Reuters reported July 7. Workers from in and outside hospitals said they have worked wi…
AI Summary: Healthcare workers in the Democratic Republic of Congo have launched strike actions amid a surging Ebola outbreak, with fatalities rising and frontline staff protesting working conditions and safety concerns. The walkouts threaten response capacity, complicating efforts to trace contacts, vaccinate and treat patients as authorities scramble to maintain basic outbreak control measures.
oncodaily - Parham Habibzadeh, Internal Medicine Resident at UPMC, shared a post on X: “JAMA Oncology: ctDNA MRD after CRLM resection identifies who benefits from ACT! Upfront surgery: MRD+ patients improved with […]
AI Summary: A growing body of evidence shows circulating tumor DNA (ctDNA) measured after colorectal liver metastasis resection can identify which patients truly benefit from adjuvant chemotherapy and who likely do not. This blood test promises more personalized postoperative care, reducing unnecessary toxicity and costs by targeting chemo to molecular minimal residual disease rather than gut instinct.


StackHealth RSS
StackHealth Time Machine
More StackHealth
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.